| Literature DB >> 26862044 |
Yongchun Zhou1, Zongrang Song2, Jing Luo3, Jijun Liu4, Yunfei Huang5, Yibin Meng6, Wentao Wang7, Dingjun Hao8.
Abstract
BACKGROUND: The objective of this study was to compare the outcomes of one-stage posterior surgery involving debridement, bone grafting, and instrumentation with and without local continuous chemotherapy and postural drainage for the treatment of lumbar spinal tuberculosis.Entities:
Mesh:
Substances:
Year: 2016 PMID: 26862044 PMCID: PMC4746790 DOI: 10.1186/s12891-016-0921-2
Source DB: PubMed Journal: BMC Musculoskelet Disord ISSN: 1471-2474 Impact factor: 2.362
Fig. 1Images from a 21-year-old man with lumbar spinal tuberculosis who underwent one-stage posterior debridement, bone grafting, and instrumentation. a–c Preoperative X-ray, MR, and CT images showing the destruction of L4 and L5 and paravertebral abscess formation. d Postoperative lateral X-ray showing fixation of L3–S1. e, f At the 24-month follow-up examination, fixation and interbody vertebral fusion were satisfactory, with no sign of tuberculosis recurrence
Fig. 2Images from a 70-year-old man with lumbar spinal tuberculosis who underwent one-stage posterior debridement, bone grafting, and instrumentation with local continuous chemotherapy and postural drainage. a–c Preoperative X-ray, MR, and CT images show the destruction of L1 and L2 and paravertebral abscess formation. d Postoperative lateral X-ray showing fixation of T12–L2. e, f X-rays obtained 6 months postoperatively show successful interbody bony fusion
Patient and surgical characteristics and outcomes of the two groups
| Characteristic | Group A ( | Group B ( |
|---|---|---|
| Sex (male) | 30 (57.7 %) | 36 (63.2 %) |
| Age at initial operation (years) | 49.9 ± 15.9 (20–71) | 50.5 ± 16.1 (21–73) |
| Operation time (min) | 215.5 ± 35.0 (146–276) | 222.6 ± 39 (157–279) |
| Intraoperative bleeding (ml) | 520.1 ± 59 (250–1000) | 522.3 ± 54 (253–1000) |
| Time to abscess disappearance (postoperative months)* | 7.4 ± 0.7 (6–12) | 5.4 ± 0.6 (5–10) |
| Time to bone fusion (postoperative months)* | 8.9 ± 0.6 (6–12) | 6.4 ± 0.5 (5–10) |
Data are presented as n (%) or mean ± standard deviation (range)
* P < 0.05
Distributions of involved vertebral bodies and lumbar fusion sites
| Group | Affected vertebra(e) | Fusion site | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| L2 | L2–3 | L3 | L4 | L3–4 | L4–5 | L5 | L2–3 | L3–4 | L4–5 | L5–S1 | |
| A ( | 2 (3.8 %) | 6 (11.5 %) | 5 (9.6 %) | 6 (11.5 %) | 9 (17.3 %) | 19 (36.5 %) | 5 (9.6 %) | 8 (15.4 %) | 13 (25 %) | 25 (48.1 %) | 6 (11.5 %) |
| B ( | 3 (5.3 %) | 7 (12.3 %) | 7 (12.3 %) | 15 (26.3 %) | 7 (12.3 %) | 12 (21.1 %) | 6 (10.5 %) | 6 (10.5 %) | 13 (22.8 %) | 27 (47.4 %) | 11 (19.3 %) |
Measures of baseline severity and surgical outcomes of the two groups
| Measure | Group A | Group B |
|---|---|---|
| ODI, % | ||
| Preoperative | 58.2 ± 14.1 | 54.2 ± 12.1 |
| 6 weeks postoperative | 20.3 ± 4.2* | 20.8 ± 3.9* |
| 16 weeks postoperative | 2.2 ± 0.4** | 1.8 ± 0.3** |
| VAS | ||
| Preoperative | 6.1 ± 1.2 | 6.2 ± 1.1 |
| 6 weeks postoperative | 2.5 ± 1.1* | 2.4 ± 1.2* |
| 16 weeks postoperative | 0.7 ± 0.4** | 0.7 ± 0.5** |
| CRP (mg/L) | ||
| Preoperative | 19.2 ± 5.1 | 18.7 ± 5.2 |
| 6 weeks postoperative*** | 9.0 ± 1.9* | 7.1 ± 1.9* |
| 16 weeks postoperative | 3.1 ± 0.5** | 2.7 ± 0.5** |
| ESR (mm/h) | ||
| Preoperative | 39.6 ± 9.9 | 39.1 ± 9.8 |
| 6 weeks postoperative*** | 24.6 ± 1.5* | 16.3 ± 1.1* |
| 16 weeks postoperative | 10.1 ± 1.0** | 9.3 ± 1.1** |
ODI Oswestry Disability Index, VAS visual analog scale, ESR erythrocyte sedimentation rate, CRP C-reactive protein
* P < 0.05 vs. preoperative
** P < 0.05 vs. 6 weeks postoperative
*** P < 0.05, group A vs. group B
Neurological recovery according to Frankel grade
| Group A | Group B | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Time point | A | B | C | D | E | A | B | C | D | E |
| Preoperative | 4 | 48 | 6 | 51 | ||||||
| Final follow-up* | 2 | 50 | 3 | 54 | ||||||
* P < 0.05 vs. preoperative